Stacey Winter joined Wedbush Securities in 2002 and currently serves as managing director, head of equity sales and head of ...

Douglas Ireland is a highly respected market manager overseeing Wedbush Securities' offices in Newport Beach, San Diego, ...

Tesla’s (TSLA) stock is in the midst of its longest losing streak since going public 15 years ago, with shares falling for ...

Dan Ives, Wedbush Securities global head of technology research, joins CNBC's 'Squawk on the Street' to discuss outlooks on ...

Wedbush Securities is making a big statement on Tesla (NASDAQ:TSLA), naming it to its Best Ideas List even though the stock has had a rough start to the year. According to analyst Dan Ives ...

Analysts at Wedbush believe Palantir could secure additional government contracts following channel checks in Washington, D.C ...

New York (CNN) — US stocks slid Thursday and the S&P 500 closed in correction, down more than 10% from its record high in ...

Sutro Biopharma (NASDAQ:STRO – Get Free Report) was downgraded by research analysts at Wedbush from an “outperform” rating to a “neutral” rating in a research note issued on Friday, MarketBeat.com ...

After doing channel checks inside Washington, D.C., Wedbush Securities has added confidence that Palantir Technologies (PLTR) ...

Nvidia ( NASDAQ: NVDA) is set to host its annual GTC conference next week and with tech stocks under pressure from tariffs, concerns of a recession and negative sentiment, Wedbush Securities believes ...

Voyager Therapeutics (NASDAQ:VYGR – Get Free Report)‘s stock had its “outperform” rating reissued by analysts at Wedbush in a ...